STOCK TITAN

Accolade to Announce Fiscal Third Quarter 2022 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Accolade, Inc. (NASDAQ: ACCD) will release its fiscal Q3 2022 financial results on January 10, 2022, after market close. A conference call will follow at 4:30 p.m. E.T. to discuss these results. The call can be accessed by dialing 1-833-519-1281 for U.S. participants or 1-914-800-3853 for international participants, using conference ID # 6077524. A live audio webcast will also be available on the company's investor relations website. The replay of the call will be accessible for approximately 90 days after the event.

Positive
  • Accolade's personalized health and benefits solutions support lower healthcare costs and improve health outcomes.
  • The company has consistently received consumer satisfaction ratings over 90 percent.
Negative
  • None.

SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal third quarter 2022 financial results on Monday, January 10, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing 1-833-519-1281 for U.S. participants, or 1-914-800-3853 for international participants, referencing conference ID # 6077524; or via a live audio webcast that will be available online at http://ir.accolade.com. A presentation will accompany the conference call and will be available via the webcast.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Accolade, Inc.

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the healthcare system with empathy, expertise and through exceptional service while supporting them in lowering the cost of care and improving health outcomes. Accolade blends technology-enabled health and benefits solutions, specialized support from Accolade Health Assistants® and Clinicians, and access to expert medical opinion services and virtual primary care. Accolade consistently receives consumer satisfaction ratings over 90 percent. For more information, visit Accolade on LinkedIn, Twitter, Instagram and Facebook and at accolade.com.

Investor Contact:

Todd Friedman, IR@accolade.com

Asher Dewhurst, accolade@westwicke.com

Media Contact:

Megan Torres, Media, Media@accolade.com

Source: Accolade


FAQ

When will Accolade release its fiscal Q3 2022 financial results?

Accolade will release its fiscal Q3 2022 financial results on January 10, 2022, after market close.

What time is Accolade's conference call for fiscal Q3 2022 results?

The conference call will take place at 4:30 p.m. E.T. on January 10, 2022.

How can I access Accolade's conference call?

You can access the conference call by dialing 1-833-519-1281 for U.S. participants or 1-914-800-3853 for international participants, using conference ID # 6077524, or via a live audio webcast on Accolade's investor relations website.

Will there be a replay of Accolade's Q3 2022 results call?

Yes, a replay of the call will be available for on-demand listening shortly after completion and will remain available for approximately 90 days.

Accolade, Inc.

NASDAQ:ACCD

ACCD Rankings

ACCD Latest News

ACCD Stock Data

271.41M
77.99M
3.16%
83.54%
4.52%
Health Information Services
Services-business Services, Nec
Link
United States of America
PLYMOUTH MEETING